2024 Q1 Form 10-Q Financial Statement
#000155203324000040 Filed on April 25, 2024
Income Statement
Concept | 2024 Q1 |
---|---|
Revenue | $1.021B |
YoY Change | 8.6% |
Cost Of Revenue | $406.3M |
YoY Change | 25.05% |
Gross Profit | $614.9M |
YoY Change | -0.08% |
Gross Profit Margin | 60.21% |
Selling, General & Admin | $305.6M |
YoY Change | -10.25% |
% of Gross Profit | 49.7% |
Research & Development | |
YoY Change | |
% of Gross Profit | |
Depreciation & Amortization | $134.0M |
YoY Change | 3.32% |
% of Gross Profit | 21.79% |
Operating Expenses | $439.5M |
YoY Change | -44.72% |
Operating Profit | $175.4M |
YoY Change | 20.8% |
Interest Expense | -$58.60M |
YoY Change | -181.62% |
% of Operating Profit | -33.41% |
Other Income/Expense, Net | -$13.40M |
YoY Change | -80.75% |
Pretax Income | $83.00M |
YoY Change | 9.79% |
Income Tax | $13.00M |
% Of Pretax Income | 15.66% |
Net Earnings | $65.10M |
YoY Change | 23.76% |
Net Earnings / Revenue | 6.37% |
Basic Earnings Per Share | $0.34 |
Diluted Earnings Per Share | $0.33 |
COMMON SHARES | |
Basic Shares Outstanding | 194.0M shares |
Diluted Shares Outstanding | 195.3M shares |
Balance Sheet
Concept | 2024 Q1 |
---|---|
SHORT-TERM ASSETS | |
Cash & Short-Term Investments | $436.2M |
YoY Change | -1.25% |
Cash & Equivalents | $433.6M |
Short-Term Investments | $2.600M |
Other Short-Term Assets | $212.1M |
YoY Change | -26.74% |
Inventory | |
Prepaid Expenses | $146.9M |
Receivables | $774.6M |
Other Receivables | $0.00 |
Total Short-Term Assets | $1.423B |
YoY Change | 3.03% |
LONG-TERM ASSETS | |
Property, Plant & Equipment | $293.8M |
YoY Change | 40.24% |
Goodwill | $5.170B |
YoY Change | -7.17% |
Intangibles | $3.450B |
YoY Change | -5.13% |
Long-Term Investments | $302.8M |
YoY Change | 438.79% |
Other Assets | $301.5M |
YoY Change | -60.64% |
Total Long-Term Assets | $9.602B |
YoY Change | -5.7% |
TOTAL ASSETS | |
Total Short-Term Assets | $1.423B |
Total Long-Term Assets | $9.602B |
Total Assets | $11.02B |
YoY Change | -4.66% |
SHORT-TERM LIABILITIES | |
YoY Change | |
Accounts Payable | $281.3M |
YoY Change | -5.73% |
Accrued Expenses | $277.8M |
YoY Change | 368.47% |
Deferred Revenue | |
YoY Change | |
Short-Term Debt | $0.00 |
YoY Change | |
Long-Term Debt Due | $77.50M |
YoY Change | -32.37% |
Total Short-Term Liabilities | $861.0M |
YoY Change | -1.98% |
LONG-TERM LIABILITIES | |
Long-Term Debt | $5.253B |
YoY Change | -3.7% |
Other Long-Term Liabilities | $166.7M |
YoY Change | -2.74% |
Total Long-Term Liabilities | $5.420B |
YoY Change | -3.67% |
TOTAL LIABILITIES | |
Total Short-Term Liabilities | $861.0M |
Total Long-Term Liabilities | $5.420B |
Total Liabilities | $6.949B |
YoY Change | -3.9% |
SHAREHOLDERS EQUITY | |
Retained Earnings | $2.199B |
YoY Change | -11.27% |
Common Stock | $2.453B |
YoY Change | 5.52% |
Preferred Stock | |
YoY Change | |
Treasury Stock (at cost) | $313.5M |
YoY Change | 7.33% |
Treasury Stock Shares | |
Shareholders Equity | $4.075B |
YoY Change | |
Total Liabilities & Shareholders Equity | $11.02B |
YoY Change | -4.66% |
Cashflow Statement
Concept | 2024 Q1 |
---|---|
OPERATING ACTIVITIES | |
Net Income | $65.10M |
YoY Change | 23.76% |
Depreciation, Depletion And Amortization | $134.0M |
YoY Change | 3.32% |
Cash From Operating Activities | $54.00M |
YoY Change | -30.23% |
INVESTING ACTIVITIES | |
Capital Expenditures | $62.40M |
YoY Change | -6.17% |
Acquisitions | |
YoY Change | |
Other Investing Activities | $0.00 |
YoY Change | -100.0% |
Cash From Investing Activities | -$62.40M |
YoY Change | -39.77% |
FINANCING ACTIVITIES | |
Cash Dividend Paid | $20.80M |
YoY Change | 0.0% |
Common Stock Issuance & Retirement, Net | |
YoY Change | |
Debt Paid & Issued, Net | |
YoY Change | |
Cash From Financing Activities | -31.30M |
YoY Change | -74.34% |
NET CHANGE | |
Cash From Operating Activities | 54.00M |
Cash From Investing Activities | -62.40M |
Cash From Financing Activities | -31.30M |
Net Change In Cash | -39.70M |
YoY Change | -72.86% |
FREE CASH FLOW | |
Cash From Operating Activities | $54.00M |
Capital Expenditures | $62.40M |
Free Cash Flow | -$8.400M |
YoY Change | -177.06% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2024Q1 | us-gaap |
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
|
P1Y | |
CY2024Q1 | us-gaap |
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
|
P1Y | |
CY2024Q1 | us-gaap |
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
|
||
CY2024Q1 | us-gaap |
Other Cost And Expense Operating
OtherCostAndExpenseOperating
|
406300000 | usd |
CY2023Q1 | us-gaap |
Other Cost And Expense Operating
OtherCostAndExpenseOperating
|
380800000 | usd |
CY2024Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
305600000 | usd |
CY2023Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
284600000 | usd |
CY2024Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
134000000.0 | usd |
CY2023Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
129700000 | usd |
CY2024Q1 | us-gaap |
Restructuring Charges
RestructuringCharges
|
18200000 | usd |
CY2023Q1 | us-gaap |
Restructuring Charges
RestructuringCharges
|
0 | usd |
CY2024Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
864100000 | usd |
CY2023Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
795100000 | usd |
CY2024Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
157200000 | usd |
CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
145200000 | usd |
CY2024Q1 | us-gaap |
Interest Expense
InterestExpense
|
68700000 | usd |
CY2023Q1 | us-gaap |
Interest Expense
InterestExpense
|
71800000 | usd |
CY2024Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
5400000 | usd |
CY2023Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
5800000 | usd |
CY2024Q1 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
4700000 | usd |
CY2023Q1 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
3100000 | usd |
CY2024Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-15700000 | usd |
CY2023Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-6800000 | usd |
CY2024Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-74100000 | usd |
CY2023Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-69600000 | usd |
CY2024Q1 | us-gaap |
Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
|
83000000.0 | usd |
CY2023Q1 | us-gaap |
Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
|
75600000 | usd |
CY2024Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
13000000.0 | usd |
CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
18600000 | usd |
CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
70000000.0 | usd |
CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
57000000.0 | usd |
CY2024Q1 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
0 | usd |
CY2023Q1 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
-100000 | usd |
CY2024Q1 | us-gaap |
Profit Loss
ProfitLoss
|
70000000.0 | usd |
CY2023Q1 | us-gaap |
Profit Loss
ProfitLoss
|
56900000 | usd |
CY2024Q1 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
4900000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
4300000 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
65100000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
52600000 | usd |
CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
0.34 | |
CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
0.27 | |
CY2024Q1 | us-gaap |
Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
|
0 | |
CY2023Q1 | us-gaap |
Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
|
0 | |
CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.34 | |
CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.27 | |
CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
0.33 | |
CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
0.27 | |
CY2024Q1 | us-gaap |
Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
|
0 | |
CY2023Q1 | us-gaap |
Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
|
0 | |
CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.33 | |
CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.27 | |
CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
194100000 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
193000000.0 | shares |
CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
195300000 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
193900000 | shares |
CY2024Q1 | us-gaap |
Profit Loss
ProfitLoss
|
70000000.0 | usd |
CY2023Q1 | us-gaap |
Profit Loss
ProfitLoss
|
56900000 | usd |
CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
|
-10600000 | usd |
CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
|
38000000.0 | usd |
CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
|
-100000 | usd |
CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
|
700000 | usd |
CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-10500000 | usd |
CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
37300000 | usd |
CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax
|
11100000 | usd |
CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax
|
-47400000 | usd |
CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
|
2800000 | usd |
CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
|
-11800000 | usd |
CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
|
8300000 | usd |
CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
|
-35600000 | usd |
CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-2200000 | usd |
CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
1700000 | usd |
CY2024Q1 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
67800000 | usd |
CY2023Q1 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
58600000 | usd |
CY2024Q1 | us-gaap |
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
4600000 | usd |
CY2023Q1 | us-gaap |
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
3700000 | usd |
CY2024Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
63200000 | usd |
CY2023Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
54900000 | usd |
CY2024Q1 | us-gaap |
Profit Loss
ProfitLoss
|
70000000.0 | usd |
CY2023Q1 | us-gaap |
Profit Loss
ProfitLoss
|
56900000 | usd |
CY2024Q1 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
0 | usd |
CY2023Q1 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
-100000 | usd |
CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
70000000.0 | usd |
CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
57000000.0 | usd |
CY2024Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
134000000.0 | usd |
CY2023Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
129700000 | usd |
CY2024Q1 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-700000 | usd |
CY2023Q1 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-1000000.0 | usd |
CY2024Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-27100000 | usd |
CY2023Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-27400000 | usd |
CY2024Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
24100000 | usd |
CY2023Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
22100000 | usd |
CY2024Q1 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
4700000 | usd |
CY2023Q1 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
0 | usd |
CY2024Q1 | us-gaap |
Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
|
3500000 | usd |
CY2023Q1 | us-gaap |
Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
|
-100000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
60700000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
56700000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-43700000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
12200000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
28700000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
44900000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-158200000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-80900000 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
54000000.0 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
77400000 | usd |
CY2024Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
62400000 | usd |
CY2023Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
66500000 | usd |
CY2024Q1 | us-gaap |
Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
|
0 | usd |
CY2023Q1 | us-gaap |
Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
|
17500000 | usd |
CY2024Q1 | us-gaap |
Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
|
0 | usd |
CY2023Q1 | us-gaap |
Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
|
23100000 | usd |
CY2024Q1 | tru |
Payments For Investments In Nonconsolidated Affiliates And Purchase Of Convertible Notes
PaymentsForInvestmentsInNonconsolidatedAffiliatesAndPurchaseOfConvertibleNotes
|
1200000 | usd |
CY2023Q1 | tru |
Payments For Investments In Nonconsolidated Affiliates And Purchase Of Convertible Notes
PaymentsForInvestmentsInNonconsolidatedAffiliatesAndPurchaseOfConvertibleNotes
|
31900000 | usd |
CY2024Q1 | us-gaap |
Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
|
-1200000 | usd |
CY2023Q1 | us-gaap |
Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
|
-400000 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-62400000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-103600000 | usd |
CY2024Q1 | us-gaap |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net
ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet
|
264100000 | usd |
CY2023Q1 | us-gaap |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net
ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet
|
0 | usd |
CY2024Q1 | us-gaap |
Repayments Of Secured Debt
RepaymentsOfSecuredDebt
|
257100000 | usd |
CY2023Q1 | us-gaap |
Repayments Of Secured Debt
RepaymentsOfSecuredDebt
|
0 | usd |
CY2024Q1 | us-gaap |
Repayments Of Debt
RepaymentsOfDebt
|
14600000 | usd |
CY2023Q1 | us-gaap |
Repayments Of Debt
RepaymentsOfDebt
|
103600000 | usd |
CY2024Q1 | us-gaap |
Payments Of Financing Costs
PaymentsOfFinancingCosts
|
4700000 | usd |
CY2023Q1 | us-gaap |
Payments Of Financing Costs
PaymentsOfFinancingCosts
|
0 | usd |
CY2024Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
12400000 | usd |
CY2023Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
9800000 | usd |
CY2024Q1 | us-gaap |
Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
|
20800000 | usd |
CY2023Q1 | us-gaap |
Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
|
20600000 | usd |
CY2024Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
10600000 | usd |
CY2023Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
7600000 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-31300000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-122000000.0 | usd |
CY2024Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
-2900000 | usd |
CY2023Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1900000 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-42600000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-146300000 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
476200000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
585300000 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
433600000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
439000000.0 | usd |
CY2024Q1 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
2 | segment |
CY2024Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements and related disclosures in accordance with GAAP requires management to make estimates and judgments that affect the amounts reported. We believe that the estimates used in preparation of the accompanying consolidated financial statements are reasonable, based upon information available to management at this time. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These estimates and judgments affect the reported amounts of assets, liabilities and disclosure of contingent assets and liabilities at the balance sheet date, as well as the amounts of revenue and expense during the reporting period. Estimates are inherently uncertain and actual results could differ materially from the estimated amounts.</span></div> | |
CY2023Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
145400000 | usd |
CY2024Q1 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
2600000 | usd |
CY2023Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
16400000 | usd |
CY2022Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
11000000.0 | usd |
CY2024Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
4700000 | usd |
CY2023Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
1300000 | usd |
CY2024Q1 | tru |
Accounts Receivable Allowance For Credit Loss Write Off Recovery
AccountsReceivableAllowanceForCreditLossWriteOffRecovery
|
-3500000 | usd |
CY2023Q1 | tru |
Accounts Receivable Allowance For Credit Loss Write Off Recovery
AccountsReceivableAllowanceForCreditLossWriteOffRecovery
|
-1100000 | usd |
CY2024Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
17600000 | usd |
CY2023Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
11200000 | usd |
CY2024Q1 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
146900000 | usd |
CY2023Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
2700000 | usd |
CY2024Q1 | us-gaap |
Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
|
65200000 | usd |
CY2023Q4 | us-gaap |
Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
|
127800000 | usd |
CY2024Q1 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
214700000 | usd |
CY2023Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
275900000 | usd |
CY2024Q1 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | usd |
CY2023Q4 | us-gaap |
Goodwill
Goodwill
|
5176000000 | usd |
CY2024Q1 | us-gaap |
Goodwill Transfers
GoodwillTransfers
|
0 | usd |
CY2024Q1 | us-gaap |
Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
|
-5600000 | usd |
CY2024Q1 | us-gaap |
Goodwill
Goodwill
|
5170400000 | usd |
CY2024Q1 | us-gaap |
Goodwill Gross
GoodwillGross
|
5584400000 | usd |
CY2024Q1 | us-gaap |
Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
|
414000000.0 | usd |
CY2024Q1 | us-gaap |
Goodwill
Goodwill
|
5170400000 | usd |
CY2023Q4 | us-gaap |
Goodwill Gross
GoodwillGross
|
5590000000 | usd |
CY2023Q4 | us-gaap |
Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
|
414000000.0 | usd |
CY2023Q4 | us-gaap |
Goodwill
Goodwill
|
5176000000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
6264100000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
2814100000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
3450000000 | usd |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
6235100000 | usd |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
2719800000 | usd |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
3515300000 | usd |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
6235100000 | usd |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
2719800000 | usd |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
3515300000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
6264100000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
2814100000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
3450000000 | usd |
CY2024Q1 | us-gaap |
Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
|
302800000 | usd |
CY2023Q4 | us-gaap |
Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
|
291400000 | usd |
CY2024Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
103900000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
98900000 | usd |
CY2024Q1 | us-gaap |
Interest Rate Derivative Assets At Fair Value
InterestRateDerivativeAssetsAtFairValue
|
173400000 | usd |
CY2023Q4 | us-gaap |
Interest Rate Derivative Assets At Fair Value
InterestRateDerivativeAssetsAtFairValue
|
162300000 | usd |
CY2024Q1 | us-gaap |
Other Receivables
OtherReceivables
|
83300000 | usd |
CY2023Q4 | us-gaap |
Other Receivables
OtherReceivables
|
82000000.0 | usd |
CY2024Q1 | us-gaap |
Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
|
128200000 | usd |
CY2023Q4 | us-gaap |
Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
|
104800000 | usd |
CY2024Q1 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
791500000 | usd |
CY2023Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
739400000 | usd |
CY2024Q1 | us-gaap |
Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
|
239200000 | usd |
CY2023Q4 | us-gaap |
Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
|
233800000 | usd |
CY2024Q1 | us-gaap |
Equity Method Investments
EquityMethodInvestments
|
59800000 | usd |
CY2023Q4 | us-gaap |
Equity Method Investments
EquityMethodInvestments
|
53900000 | usd |
CY2024Q1 | tru |
Limited Partnership Investment
LimitedPartnershipInvestment
|
3800000 | usd |
CY2023Q4 | tru |
Limited Partnership Investment
LimitedPartnershipInvestment
|
3700000 | usd |
CY2024Q1 | us-gaap |
Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
|
302800000 | usd |
CY2023Q4 | us-gaap |
Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
|
291400000 | usd |
CY2024Q1 | us-gaap |
Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
|
4700000 | usd |
CY2023Q1 | us-gaap |
Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
|
0 | usd |
CY2024Q1 | us-gaap |
Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
|
0 | usd |
CY2024Q1 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
4700000 | usd |
CY2023Q1 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
3100000 | usd |
CY2024Q1 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
99400000 | usd |
CY2023Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
216200000 | usd |
CY2024Q1 | us-gaap |
Litigation Reserve Current
LitigationReserveCurrent
|
105200000 | usd |
CY2023Q4 | us-gaap |
Litigation Reserve Current
LitigationReserveCurrent
|
147800000 | usd |
CY2024Q1 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
138400000 | usd |
CY2023Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
125100000 | usd |
CY2024Q1 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
48600000 | usd |
CY2023Q4 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
64900000 | usd |
CY2024Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
24600000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
26200000 | usd |
CY2024Q1 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
7400000 | usd |
CY2023Q4 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
10200000 | usd |
CY2024Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
78600000 | usd |
CY2023Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
71500000 | usd |
CY2024Q1 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
502200000 | usd |
CY2023Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
661800000 | usd |
CY2024Q1 | us-gaap |
Restructuring And Related Cost Expected Cost1
RestructuringAndRelatedCostExpectedCost1
|
155000000 | usd |
CY2024Q1 | us-gaap |
Restructuring And Related Cost Cost Incurred To Date1
RestructuringAndRelatedCostCostIncurredToDate1
|
93500000 | usd |
CY2024Q1 | us-gaap |
Restructuring Charges
RestructuringCharges
|
18200000 | usd |
CY2024Q1 | us-gaap |
Severance Costs1
SeveranceCosts1
|
16800000 | usd |
CY2024Q1 | us-gaap |
Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
|
1400000 | usd |
CY2024Q1 | us-gaap |
Restructuring Charges
RestructuringCharges
|
18200000 | usd |
CY2023Q4 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
64900000 | usd |
CY2024Q1 | us-gaap |
Severance Costs1
SeveranceCosts1
|
16800000 | usd |
CY2024Q1 | us-gaap |
Payments For Restructuring
PaymentsForRestructuring
|
33000000.0 | usd |
CY2024Q1 | us-gaap |
Restructuring Reserve Translation And Other Adjustment
RestructuringReserveTranslationAndOtherAdjustment
|
-100000 | usd |
CY2024Q1 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
48600000 | usd |
CY2024Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
89800000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
81800000 | usd |
CY2024Q1 | us-gaap |
Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
|
41000000.0 | usd |
CY2023Q4 | us-gaap |
Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
|
40200000 | usd |
CY2024Q1 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
16800000 | usd |
CY2023Q4 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
15100000 | usd |
CY2024Q1 | tru |
Other Noncurrent Other Liabilities
OtherNoncurrentOtherLiabilities
|
19200000 | usd |
CY2023Q4 | tru |
Other Noncurrent Other Liabilities
OtherNoncurrentOtherLiabilities
|
16100000 | usd |
CY2024Q1 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
166700000 | usd |
CY2023Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
153200000 | usd |
CY2024Q1 | us-gaap |
Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
|
5330600000 | usd |
CY2023Q4 | us-gaap |
Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
|
5340400000 | usd |
CY2024Q1 | us-gaap |
Debt Current
DebtCurrent
|
77500000 | usd |
CY2023Q4 | us-gaap |
Debt Current
DebtCurrent
|
89600000 | usd |
CY2024Q1 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
5253100000 | usd |
CY2023Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
5250800000 | usd |
CY2024Q1 | us-gaap |
Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
|
3100000 | usd |
CY2024Q1 | us-gaap |
Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
|
1200000 | usd |
CY2024Q1 | tru |
Incremental Borrowings Amount
IncrementalBorrowingsAmount
|
1000000000 | usd |
CY2024Q1 | tru |
Incremental Borrowings Criteria Percentageof Consolidated Ebitda
IncrementalBorrowingsCriteriaPercentageofConsolidatedEBITDA
|
1 | |
CY2024Q1 | tru |
Incremental Borrowings Criteria Senior Secured Leverageratio
IncrementalBorrowingsCriteriaSeniorSecuredLeverageratio
|
4.25 | |
CY2024Q1 | tru |
Net Leverage Ratio Requirement
NetLeverageRatioRequirement
|
5.5 | |
CY2024Q1 | tru |
Covenant Dividend Restriction Amount
CovenantDividendRestrictionAmount
|
100000000 | usd |
CY2024Q1 | tru |
Covenant Dividend Restriction Percentageof Consolidated Ebitda
CovenantDividendRestrictionPercentageofConsolidatedEBITDA
|
0.100 | |
CY2024Q1 | tru |
Net Leverage Ratio Requirement Dividends
NetLeverageRatioRequirementDividends
|
4.75 | |
CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax
|
11100000 | usd |
CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
|
8300000 | usd |
CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax
|
-47400000 | usd |
CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
|
-35600000 | usd |
CY2024Q1 | us-gaap |
Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
|
0.105 | |
CY2023Q3 | us-gaap |
Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
|
0.105 | |
CY2023Q4 | us-gaap |
Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
|
0.105 | |
CY2024Q1 | us-gaap |
Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
|
20800000 | usd |
CY2017Q1 | us-gaap |
Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
|
300000000 | usd |
us-gaap |
Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
|
P3Y | ||
us-gaap |
Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
|
P3Y | ||
CY2024Q1 | tru |
Stock Repurchase Program Repurchase Amount
StockRepurchaseProgramRepurchaseAmount
|
133500000 | usd |
CY2024Q1 | us-gaap |
Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
|
166500000 | usd |
CY2024Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
100000000 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
100000000 | shares |
CY2024Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2024Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2024Q1 | tru |
Numberof Typesof Performance Obligations
NumberofTypesofPerformanceObligations
|
2 | |
CY2024Q1 | us-gaap |
Contract With Customer Refund Liability
ContractWithCustomerRefundLiability
|
0 | usd |
CY2024Q1 | tru |
Contract With Customer Liability Noncurrent Recognition Period
ContractWithCustomerLiabilityNoncurrentRecognitionPeriod
|
P2Y | |
CY2024Q1 | us-gaap |
Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
|
680000000 | usd |
CY2024Q1 | us-gaap |
Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
|
0.55 | |
CY2024Q1 | us-gaap |
Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
|
0.30 | |
CY2024Q1 | us-gaap |
Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
|
0.15 | |
CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
70000000.0 | usd |
CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
57000000.0 | usd |
CY2024Q1 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
4900000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
4300000 | usd |
CY2024Q1 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
65100000 | usd |
CY2023Q1 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
52700000 | usd |
CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
194100000 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
193000000.0 | shares |
CY2024Q1 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
1200000 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
800000 | shares |
CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
195300000 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
193900000 | shares |
CY2024Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.157 | |
CY2024Q1 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.210 | |
CY2023Q1 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.210 | |
CY2024Q1 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
45900000 | usd |
CY2023Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
45000000 | usd |
CY2024Q1 | us-gaap |
Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
|
35200000 | usd |
CY2023Q4 | us-gaap |
Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
|
34500000 | usd |
CY2024Q1 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
|
15200000 | usd |
us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
|
14000000 | usd | |
CY2024Q1 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
2 | segment |
CY2024Q1 | tru |
Numberof Corporate Units
NumberofCorporateUnits
|
1 | |
CY2024Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
1021200000 | usd |
CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
940300000 | usd |
CY2024Q1 | tru |
Adjusted Ebitda Adjustment Corporate Expense
AdjustedEBITDAAdjustmentCorporateExpense
|
33900000 | usd |
CY2023Q1 | tru |
Adjusted Ebitda Adjustment Corporate Expense
AdjustedEBITDAAdjustmentCorporateExpense
|
33800000 | usd |
CY2024Q1 | tru |
Adjusted Ebitda Adjustment Net Interest Expense
AdjustedEBITDAAdjustmentNetInterestExpense
|
63200000 | usd |
CY2023Q1 | tru |
Adjusted Ebitda Adjustment Net Interest Expense
AdjustedEBITDAAdjustmentNetInterestExpense
|
66000000.0 | usd |
CY2024Q1 | tru |
Adjusted Ebitda Adjustment Depreciationand Amortization
AdjustedEBITDAAdjustmentDepreciationandAmortization
|
134000000.0 | usd |
CY2023Q1 | tru |
Adjusted Ebitda Adjustment Depreciationand Amortization
AdjustedEBITDAAdjustmentDepreciationandAmortization
|
129700000 | usd |
CY2024Q1 | tru |
Adjusted Ebitda Adjustment Stockbased Compensation
AdjustedEBITDAAdjustmentStockbasedCompensation
|
24100000 | usd |
CY2023Q1 | tru |
Adjusted Ebitda Adjustment Stockbased Compensation
AdjustedEBITDAAdjustmentStockbasedCompensation
|
22200000 | usd |
CY2024Q1 | tru |
Adjusted Ebitda Adjustment Operating Model Optimization Program
AdjustedEBITDAAdjustmentOperatingModelOptimizationProgram
|
24400000 | usd |
CY2023Q1 | tru |
Adjusted Ebitda Adjustment Operating Model Optimization Program
AdjustedEBITDAAdjustmentOperatingModelOptimizationProgram
|
0 | usd |
CY2024Q1 | tru |
Adjusted Ebitda Adjustment Mergersand Acquisition
AdjustedEBITDAAdjustmentMergersandAcquisition
|
9200000 | usd |
CY2023Q1 | tru |
Adjusted Ebitda Adjustment Mergersand Acquisition
AdjustedEBITDAAdjustmentMergersandAcquisition
|
8900000 | usd |
CY2024Q1 | tru |
Adjusted Ebitda Adjustment Accelerated Technology
AdjustedEBITDAAdjustmentAcceleratedTechnology
|
18500000 | usd |
CY2023Q1 | tru |
Adjusted Ebitda Adjustment Accelerated Technology
AdjustedEBITDAAdjustmentAcceleratedTechnology
|
19700000 | usd |
CY2024Q1 | tru |
Adjusted Ebitda Adjustment Other
AdjustedEBITDAAdjustmentOther
|
6500000 | usd |
CY2023Q1 | tru |
Adjusted Ebitda Adjustment Other
AdjustedEBITDAAdjustmentOther
|
4600000 | usd |
CY2024Q1 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
4900000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
4300000 | usd |
CY2024Q1 | tru |
Adjusted Ebitda Adjustment Total
AdjustedEBITDAAdjustmentTotal
|
309000000.0 | usd |
CY2023Q1 | tru |
Adjusted Ebitda Adjustment Total
AdjustedEBITDAAdjustmentTotal
|
280500000 | usd |
CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
83000000.0 | usd |
CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
75600000 | usd |
CY2024Q1 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
4700000 | usd |
CY2023Q1 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
3100000 | usd |
CY2024Q1 | us-gaap |
Loss Contingency Disclosures
LossContingencyDisclosures
|
Contingencies<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal and Regulatory Matters</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are routinely named as defendants in, or parties to, various legal actions and proceedings relating to our current or past business operations. These actions generally assert claims for violations of federal or state credit reporting, consumer protection or privacy laws, or common law claims related to the unfair treatment of consumers, and may include claims for substantial or indeterminate compensatory or punitive damages, or injunctive relief, and may seek business practice changes. We believe that most of these claims are either without merit or we have valid defenses to the claims, and we vigorously defend these matters or seek non-monetary or small monetary settlements, if possible. However, due to the uncertainties inherent in litigation, we cannot predict the outcome of each claim in each instance.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, we also are subject to governmental and regulatory examinations, information-gathering requests, investigations and proceedings (both formal and informal), certain of which may result in adverse judgments, settlements, fines, penalties, injunctions or other relief. In connection with formal and informal investigations and inquiries by regulators, we sometimes receive civil investigative demands, requests, subpoenas and orders seeking documents, testimony, and other information in connection with various aspects of our activities.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In view of the inherent unpredictability of legal and regulatory matters, particularly where the damages sought are substantial or indeterminate or when the proceedings or investigations are in the early stages, we cannot determine with any degree of certainty the timing or ultimate resolution of legal and regulatory matters or the eventual loss, fines or penalties, if any, that may result from such matters. We establish reserves for legal and regulatory matters when those matters present loss contingencies that are both probable and can be reasonably estimated. However, for certain of the matters, we are not able to reasonably estimate our exposure because damages or penalties have not been specified and (i) the proceedings are in early stages, (ii) there is uncertainty as to the likelihood of a class being certified or the ultimate size of the class, (iii) there is uncertainty as to the outcome of similar matters pending against our competitors, (iv) there are significant factual issues to be resolved, and/or (v) there are legal issues of a first impression being presented. The actual costs of resolving legal and regulatory matters, however, may be substantially higher than the amounts reserved for those matters, and an adverse outcome in certain of these matters could have a material adverse effect on our consolidated financial statements in particular quarterly or annual periods. We accrue amounts for certain legal and regulatory matters for which losses were considered to be probable of occurring based on our best estimate of the most likely outcome. It is reasonably possible actual losses could be significantly different from our current estimates. In addition, there are some matters for which it is reasonably possible that a loss will occur, however we cannot estimate a range of the potential losses for these matters. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To reduce our exposure to an unexpected significant monetary award resulting from an adverse judicial decision, we maintain insurance that we believe is appropriate and adequate based on our historical experience. We regularly advise our insurance carriers of the claims, threatened or pending, against us in legal and regulatory matters and generally receive a reservation of rights letter from the carriers when such claims exceed applicable deductibles. We are not aware of any significant monetary claim that has been asserted against us, except for the lawsuit filed by the Consumer Financial Protection Bureau (the “CFPB”) referenced below, that would not have some level of coverage by insurance after the relevant deductible, if any, is met.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2024 and December 31, 2023, we have accrued $105.2 million and $147.8 million, respectively, for legal and regulatory matters. These amounts were recorded in other accrued liabilities in the Consolidated Balance Sheets and the associated expenses were recorded in selling, general and administrative expenses in the Consolidated Statements of Operations. Legal fees incurred in connection with ongoing litigation are considered period costs and are expensed as incurred.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CFPB Matters</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, we received a Notice and Opportunity to Respond and Advise (“NORA”) letter from the CFPB, informing us that the CFPB’s Enforcement Division was considering whether to recommend that the CFPB take legal action against us and certain of our executive officers. The NORA letter alleged that we failed to comply with and timely implement a consent order issued by the CFPB in January 2017 (the “2017 Consent Order”), and further alleged additional violations related to Consumer Interactive’s marketing practices. On September 27, 2021, the Enforcement Division advised us that it had obtained authority to pursue an enforcement action. On April 12, 2022, after failed settlement negotiations with the CFPB related to the matter, the CFPB filed a lawsuit against us, Trans Union LLC, TransUnion Interactive, Inc. (collectively, the “TU Entities”) and the former President of Consumer Interactive, John Danaher, in the United States District Court for the Northern District of Illinois seeking restitution, civil money penalties, and injunctive relief, among other remedies, and alleging that the TU Entities violated the 2017 Consent Order, engaged in deceptive acts and practices in marketing the TransUnion Credit Monitoring product, failed to obtain signed written authorizations from consumers before debiting their bank accounts for the TransUnion Credit Monitoring product and diverted consumers from their free annual file disclosure into paid subscription products. The CFPB further alleges that Mr. Danaher violated the 2017 Consent Order and that we and Trans Union LLC provided substantial assistance to TransUnion Interactive, Inc. in violating the 2017 Consent Order and the law. We continue to believe that our marketing practices are lawful and appropriate and that we have been, and remain, in compliance with the 2017 Consent Order, and we will vigorously defend against allegations to the contrary in such proceedings. We continue to be in active litigation on this matter.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2024 and December 31, 2023, we have accrued $56.0 million in connection with this matter and there is a reasonable possibility that a loss in excess of the amount accrued may be incurred, and such an outcome could have a material adverse effect on our results of operations and financial condition. However, any possible loss or range of loss in excess of the amount accrued is not reasonably estimable at this time. In addition, we have and will continue to incur increased costs litigating this matter. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2024, we received a NORA letter from the CFPB, informing us that the CFPB’s Enforcement Division is considering whether to recommend that the CFPB take legal action against us related to our dispute handling practices and procedures. The </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NORA letter alleges that Trans Union LLC violated the Fair Credit Reporting Act’s requirements to conduct a reasonable reinvestigation of disputed information and follow reasonable procedures to assure maximum possible accuracy of the information in consumer reports, and the Consumer Financial Protection Act’s prohibition of unfair, deceptive, and abusive acts or practices. Should the CFPB commence an action against us, it may seek restitution, disgorgement, civil monetary penalties, injunctive relief or other corrective action. We cannot provide assurance that the CFPB will not ultimately commence a legal action against us in this matter, nor are we able to predict the likely outcome, which could have a material adverse effect on our results of operations and financial condition. As of March 31, 2024, we are not able to reasonably estimate our potential loss or range of loss related to this matter.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Argus Department of Justice Matter</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have cooperated with an investigation originating from the civil division of the United States Attorney’s Office for the Eastern District of Virginia related to Argus’s use of certain data it collected under certain government contracts. We acquired Argus in connection with our acquisition of Verisk Financial Services (“VF”) in April 2022. This matter pertained to alleged conduct that commenced before we acquired Argus. We have cooperated with Verisk Analytics, Inc. (the “Seller”) to respond to the Department of Justice’s (“DOJ”) investigation and, along with the Seller, finalized a $37.0 million settlement with the DOJ (the “Settlement”).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the stock purchase agreement Trans Union LLC entered into with the Seller pursuant to which we acquired VF, including Argus, the Seller agreed to indemnify us for certain losses with respect to this matter, including all losses directly resulting from any settlement agreement with the DOJ in connection with this matter, including civil money penalties, remediation costs and fees and expenses. During the three months ended March 31, 2024, the Settlement was paid in full to the DOJ and the indemnification receivable was collected.</span></div> | |
CY2024Q1 | us-gaap |
Litigation Reserve Current
LitigationReserveCurrent
|
105200000 | usd |
CY2023Q4 | us-gaap |
Litigation Reserve Current
LitigationReserveCurrent
|
147800000 | usd |
CY2023Q1 | us-gaap |
Other Cost And Expense Operating
OtherCostAndExpenseOperating
|
380800000 | usd |
CY2023Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
284600000 | usd |
CY2023Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
795100000 | usd |
CY2023Q2 | us-gaap |
Other Cost And Expense Operating
OtherCostAndExpenseOperating
|
387000000.0 | usd |
us-gaap |
Other Cost And Expense Operating
OtherCostAndExpenseOperating
|
767800000 | usd | |
CY2023Q2 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
292500000 | usd |
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
577100000 | usd | |
CY2023Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
809600000 | usd |
us-gaap |
Operating Expenses
OperatingExpenses
|
1604700000 | usd | |
CY2023Q3 | us-gaap |
Other Cost And Expense Operating
OtherCostAndExpenseOperating
|
368800000 | usd |
us-gaap |
Other Cost And Expense Operating
OtherCostAndExpenseOperating
|
1136800000 | usd | |
CY2023Q3 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
290800000 | usd |
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
867700000 | usd | |
CY2023Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
1205000000 | usd |
us-gaap |
Operating Expenses
OperatingExpenses
|
2809600000 | usd | |
CY2024Q1 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false | |
CY2024Q1 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
CY2024Q1 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false |